How a prior early abortion affects later pregnancy complications and outcomes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective multicenter cohort enrolling women who had an induced abortion in early pregnancy (<12 weeks) at three hospitals across China and following them forward to document subsequent pregnancy outcomes. Investigators will collect clinical information and record pregnancy complications through scheduled follow-ups and medical records. Eligible participants are permanent local residents under 40 without a prior history of adverse pregnancy or childbirth and who can provide informed consent and reliable contact information. The multicenter design is intended to capture regional variation in real-world outcomes rather than test a specific treatment intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* women have induced abortion in early pregnancy (\<12 weeks of gestation).
* permanent population and no tendency to move.
* normal language expression and understanding ability, able to understand research content.
* be able and willing to provide written informed consent and effective contact information, and be willing to cooperate with follow-up investigations.

Exclusion Criteria:

* above the age of 40
* with history of adverse pregnancy and childbirth

Where it's running

• Zhongshan Boai Hospital
  Zhongshan, Guangdong, China Recruiting
• Zhangjiakou Maternal and Child Health Hospital
  Zhangjiakou, Hebei, China Recruiting
• Daqing People's Hospital
  Daqing, Heilongjiang, China Recruiting
• Changzhou Maternal and Child Health Hospital
  Changzhou, Jiangsu, China Recruiting
• Yangzhou Maternal and Child Health Hospital
  Yangzhou, Jiangsu, China Recruiting
• People's Hospital of Inner Mongolia Autonomous Region
  Hohhot, Mongolia Autonomous, China Recruiting

Study contacts

• Principal investigator: Pei Kaiyan — National Research Institute for Family Planning (NRIFP)
• Study coordinator: Jiang Xue, M.D.
• Email: jiangxue012800@163.com
• Phone: +86 18011490663

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Integrated digital e-clinic for mental health and reproductive health for women and adolescent girls in Jordan

  This project tests a digital e-clinic to provide mental health, psychosocial support, and reproductive health information to women and adolescent girls in Jordan, including Syrian refugees.

  Recruiting Jordan University of Science and Technology · Irbid · NCT07861945

• Comprehensive sexuality education and mobile health services for Sierra Leonean adolescents

  This trial tests whether providing comprehensive sexuality education and mobile reproductive health services in secondary schools can improve health, well-being, and economic outcomes for adolescents in Sierra Leone.

  Recruiting Guttmacher Institute · Freetown · NCT07860723

• Anti-Inflammatory Diet and Exercise for Reproductive Health in Adolescent Girls

  This study tests whether a 16-week anti-inflammatory Mediterranean-style diet, alone or with a supervised exercise program, can improve diet quality and reproductive health in girls aged 14–19 in Poland.

  Recruiting at 2 sites Poznan University of Physical Education · Poznan, Greater Poland Voivodeship and 1 other locations · NCT07834489

• Diphenhydramine added to standard sedation for first-trimester abortion

  This trial tests whether giving diphenhydramine with standard moderate sedation improves pain control during first-trimester uterine aspiration for adults.

  Recruiting Phase 4 University of Rochester · Rochester, New York · NCT07542730

• Cabergoline to prevent lactation and ease breast symptoms after abortion or pregnancy loss

  This trial will test whether a single 1 mg oral dose of cabergoline can prevent lactation and reduce breast symptoms in people aged 18 and older having an abortion or pregnancy loss at 12–18 weeks.

  Recruiting Phase 2 Maimonides Medical Center · Brooklyn, New York · NCT07492160

• Paracervical Block With Ketorolac and Lidocaine for Osmotic Dilator Placement

  This study tests whether a ketorolac and lidocaine injection around the cervix improves pain control for people needing osmotic dilators before a second-trimester abortion.

  Recruiting Phase 2 Rush University Medical Center · Chicago, Illinois · NCT07487246

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.